Loading ....

The FDA is considering authorizing Pfizer’s COVID vaccine booster shot for those who are high-risk or 65 and older. It comes as the Delta variant surge appears to be peaking nationally, according to researchers advising the CDC. Nancy Chen has the latest.
Read More

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here